Prospective Study to Identify Molecular Mechanisms of Clinical Resistance to Standard First-line Therapy in Patients With Metastatic Colorectal Cancer
This is a multicentre translational study to understand therapeutic resistance in patients
undergoing first-line chemotherapy (FOLFOX/Avastin, or FOLFIRI/Avastin) for metastatic
colorectal cancer. Tissue samples from liver metastasis will be collected and banked before
the start of chemotherapy and at the time of progression. Additionally, blood samples will
be drawn monthly and stored in the tissue biobank.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society